Overcoming Barriers to Treatment of Opioid Use Disorder | Substance Use and Addiction | JAMA
On January 14, 2021, days before a change in presidential administrations, the US Department of Health and Human Services (HHS) announced a plan to publish Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder “pursuant to 21 USC §823(g)(2)(H)(i)(II),” a provision of the Drug Addiction and Treatment Act of 2000 (DATA 2000). 1 This announcement caused a mix of enthusiasm, skepticism, and confusion in the medical community, and the retraction of the plan to publish the guideline less than 2 weeks later by the Biden administration has created an opport...
Source: jamanetwork.com